Anti-Human CD20 Recombinant Antibody(Obinutuzumab)

Name: Anti-Human CD20 Recombinant Antibody(Obinutuzumab)
Brand: KMD Bioscience
SKU: YR1155

YR1155

科研级 Obinutuzumab ( 阿托珠单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Obinutuzumab

DATASHEET MSDS

Product Description

Alias	科研级 Obinutuzumab ( 阿托珠单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Obinutuzumab
Catalog Number	YR1155
Molecular Name	Obinutuzumab
Host	Mouse
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Obinutuzumab (called afutuzumab until 2009) is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer treatment.
CAS Number	949142-50-1
Application	IP, IF, FuncS, FCM, Neut, ELISA, ICC
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	150 kDa
Target	CD20[Homo sapiens]

Login